Abstract
Tooth development is regulated by sequential and reciprocal epithelium-mesenchymal interactions and their related molecular signaling pathways, such as bone morphogenetic proteins (BMPs). Among the 14 types of BMPs, BMP9 (also known as growth differentiation factor 2) is one of the most potent BMPs to induce osteogenic differentiation of mesenchymal stem cells. The purpose of this study was to examine potential roles of BMP9 signaling in tooth development. First, we detected the expression pattern of BMP9 in tooth germ during postnatal tooth development, and we found that BMP9 was widely expressed in odontoblasts, ameloblasts, dental pulp cells, and osteoblasts in alveolar bones. Then, we established a BMP9-KO mouse model. Gross morphological examination revealed that the tooth cusps of BMP9-KO mice were significantly abraded with shorter roots. Micro-computed tomography and three-dimensional reconstruction analysis indicated that the first molars of the BMP9-KO mice exhibited a reduced thickness dentin, enlarged pulp canals, and shortened roots, resembling the phenotypes of the common hereditary dental disease dentinogenesis imperfecta. Further, the alveolar bone of the BMP9-KO mutants was found to be shorter and had a decreased mineral density and trabecular thickness and bone volume fraction compared with that of the wild-type control. Mechanistically, we demonstrated that both dentin sialophosphoprotein and dentin matrix protein 1 were induced in dental stem cells by BMP9, whereas their expression was reduced when BMP9 was silenced. Further studies are required to determine whether loss of or decreased BMP9 expression is clinically associated with dentinogenesis imperfecta. Collectively, our results strongly suggest that BMP9 may play an important role in regulating dentinogenesis and tooth development. Further research is recommended into the therapeutic uses of BMP9 to regenerate traumatized and diseased tissues and for the bioengineering of replacement teeth.
Introduction
Tooth development is regulated by sequential and reciprocal epithelium-mesenchymal interactions and their related molecular signaling [1,2]. Tooth formation is a complex process that involves many types of dental stem cells and growth and transcriptional factors, in which multiple signaling pathways converge to regulate enamel and dentin formation [3 –10]. Enamel formation results from the dental inner enamel epithelium cells differentiating into ameloblasts and dentin originates from mesenchyme that differentiate into odontoblasts in a spatiotemporal pattern [11]. Dentin sialophosphoprotein (Dspp) and dentin matrix protein 1 (Dmp1) are highly expressed in odontoblasts, and they are essential for the development of dentin formation [7,12 –14]. Dspp and Dmp1 mutants in both human and mice exhibit abnormal teeth, such as dentinogenesis imperfecta, and dentin hypomineralization [15,16]. As one of the five types of dental stem cells, the stem cells from apical papilla (SCAPs) reside in the apical papilla of immature teeth with an underdeveloped apex. SCAP cells are essential for the development of the tooth, and they can differentiate into odontoblasts for the formation of root dentin [17]. We and others have demonstrated that SCAPs are capable of differentiating into osteo-/odontogenic lineages both in vitro and in vivo [18 –20].
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-β (TGF-β) superfamily and play important roles in bone formation, dental development, and stem cell differentiation [21]. It has been recently demonstrated that BMPs, such as BMP2, BMP4, and BMP7, significantly impact tooth development. BMP2 is considered a contributor to postnatal tooth development and regulates ameloblast and odontoblast differentiation [22,23]. Under the inactivation of BMP4 in the dental mesenchyme, the molar development was affected [24]. The expression of BMP7 was detected in the oral and dental epithelium at the initiation stage of tooth formation, then in odontoblasts and ameloblasts at a later stage [25]. However, little has been reported about possible roles of BMP9 signaling in tooth development. BMP9, also known as growth differentiation factor 2, is a relatively poorly characterized member of the BMP family, which was first isolated from fetal mouse liver cDNA libraries [26]. We previously demonstrated that, among the 14 types of human BMPs, BMP9 is one of the most potent factors that can induce osteogenic differentiation of mesenchymal stem cells (MSCs) both in vivo and in vitro [27,28]. We also found that BMP9 can effectively induce odontoblastic differentiation of SCAP cells and upregulate odontoblastic differentiation markers expression in vitro [18]. Further, we demonstrated that BMP9 acts synergistically with Wnt/β-catenin signaling, another family of critical regulators for tooth development, in promoting odontoblast differentiation of SCAPs [19]. These findings strongly suggest that BMP9 may play an important role in regulating tooth development. Thus, it is critical to investigate the potential functional roles of BMP9 during tooth development.
Materials and Methods
Animals
All animal studies were conducted by following the guidelines approved by the Institutional Animal Care and Use Committee (ACUP#71826). The use and care of animals strictly followed the NIH guidelines stipulated in the approved studies. All mice were housed in groups of 2–4 mice per cage in biosafety barriers with a controlled light cycle and given sterile food and water ad libitum. The light-dark cycle was 1:1 with lights on at 7:00 am. Room temperature was 18°C ± 2°C, and humidity was 55% ± 10%. The animals were euthanized with CO2 overdose followed by cervical dislocation. Tissues were collected for further micro-computed tomography (micro-CT) and/or histologic analyses. Wild-type mice aged on PN4, PN7, PN11, and PN15 (n = 3 each group) were used for detecting the expression pattern of BMP9 in tooth germ during postnatal tooth development. Further, 3-month-old, male BMP9 null mice and wild-type littermates (n = 6 each group) were used for investigating the function of BMP9 in tooth-alveolar bone complex development.
Generation of BMP9 knockout (BMP9-KO) mice
BMP9 null mutants, hereafter referred to as BMP9-KO, were generated in The University of Chicago Transgenic Core Facility by using commercially available ES cells with the GDF2tm1(from KOMP, Knockout Mouse Project Repository,

Gross morphology of teeth in the BMP9-KO mice.
For genotyping of the mutant mice, the genomic DNA was isolated from mouse tail samples. Specifically, the mouse tail biopsies were incubated in alkaline lysis buffer (0.2 M NaOH, 1 mM EDTA) for 30 min at 85°C. Lysates were diluted 1: 5 in molecular-grade water and used as templates for touchdown polymerase chain reaction. Genotypes were confirmed by using primers targeted for amplification of exon1, exon2, lacz, and neo (Fig. 2A, b). The primer pair (PP) sequences are as follows: PP1, 5′-TGAGTCCCATCTCCATCCTC-3′ and 5′-ATGCAGGACCGTACCAGAAC-3′; PP2, 5′-GGCATCTTGCTCTGAAGGAC-3′ and 5′-GGGCAGTCAGAAAACTCAGC-3′; PP3,5′-CAGTAGTCAGCATCCTTTCC-3′and 5′-GCTGGCTTGGTCTGTCTGTCCTA-3′; and PP4, 5′-GCAGCCTCTGTTCCACATACACTTCA-3′ and 5′-AGTTTCTGCCTGGTTTCCTG-3′.
Hematoxylin and eosin and immunohistochemistry staining
The mandible samples were harvested and fixed in neutral paraformaldehyde solution (Solarbio, Beijing, China) for 2 days, demineralized with EDTA (Biosharp, China) solution, dehydrated through graded alcohol, and finally embedded in paraffin. The embedded samples were serially sectioned, deparaffinized, rehydrated, and subjected to hematoxylin and eosin (H & E; Solarbio, Beijing, China) staining.
The immunohistochemical staining was carried out as previously described [29
–31]. Briefly, the slides were blocked and incubated with the primary antibody (Polyclonal rabbit anti-BMP9, 1:100; Thermo Fisher, U.S.;
Micro-CT analysis
Mandibles and maxillae were harvested from 3-month-old BMP9-KO and wild-type mice, fixed in neutral paraformaldehyde solution (Solarbio, Beijing, China) for 2 days, and scanned with micro-CT (Viva CT 40; Scanco Medical, Bassersdorf, Switzerland) at 70 kVp, 114 uA with a 15-μm voxel size. Three-dimensional (3-D) images were analyzed by Image Processing Language to evaluate the tooth and bone volumes.
Digital images were acquired from micro-CT imaging and were analyzed by measuring root length, root dentin thickness, the height of alveolar ridge, trabecular thickness (
3-D reconstruction analysis of the tooth
The teeth of mice were reconstructed by importing the micro-CT DICOM dataset into Mimics 17.0 (Materialise NV, Leuven, Belgium) system. The distance from the amelocemental junction to the top of the mesial root was chosen for measuring the length of the root. The width of the apical foramen was determined in the mesial root in buccolingual directions. In BMP9-KO mice and wild-type mice, sections at the 1/2 length of the mesial root were selected to measure the thickness of radicular dentin.
Cell culture, recombinant adenoviruses
The immortalized mouse dental apical papilla (iSCAPs) were previously characterized [18]. The 293 pTP line was used for adenovirus amplification [32]. Both iSCAP and 293pTP cells were maintained in complete Dulbecco's modified Eagle's medium (Sigma-Aldrich, St. Louis, MO) containing 10% fetal bovine serum (GIBCO, CA), 100 units of penicillin (Sigma-Aldrich), and 100 μg of streptomycin (Sigma-Aldrich) at 37°C in 5% CO2. Recombinant adenoviruses overexpressing BMP9, green fluorescent protein (GFP), or silencing expressing BMP9 (siBMP9) were constructed as previously reported [33]. Polybrene (10 μg/mL; Sigma-Aldrich) was used to enhance transduction efficiency for adenoviral infection [34].
Alkaline phosphatase histochemical staining and quantification assays
The iSCAPs were seeded in 24-well plates and infected with indicated multiplicty of infection (MOI) values of AdGFP, AdBMP9, or AdsiBMP9. Polybrene (10 μg/mL) was used to enhance transduction efficiency for adenoviral infection. At 48 h after the infection, GFP signal or red fluorescent protein (RFP) signal of the infected iSCAPs was assessed under a fluorescence microscope (Carl Zeiss Microimaging GmbH, Gottingen, Germany). The infection efficiency was indicated by the GFP or RFP expression proportion of the cells. Alkaline phosphatase (ALP) histochemical staining was carried out by using the NBT/BCIP staining kit (Beyotime-Bio, China), and ALP activity was assessed quantitatively with the ALP assay kit (Beyotime-Bio, China) on day 5. Each assay condition was performed in triplicate, and the results were repeated in at least three independent experiments. ALP activity was normalized by total cellular protein concentrations determined by the bicinchoninic acid Protein Assay Kit (Beyotime-Bio, China).
RNA isolation, reverse transcription, and quantitative real-time PCR
Total RNA was isolated by using the Trizol reagent (Takara, Japan), and it was subjected to reverse transcription by using the cDNA Reverse Transcription Kit (Takara, Japan). The quantitative real-time PCR analyses were carried out in the ABI Prism 7,500 Real-Time PCR System (Applied Biosystems, Foster City, CA) with the SYBR Green PCR master mix reagent (Takara, Japan). Briefly, the quantitative real-time PCR reaction cycling program was 94°C for 2 min 30 s for 1 cycle; 94°C for 25 s, 65°C for 30 s, and 72°C for 40 s for 10 cycles decreasing 1°C per cycle; and finally, 94°C for 25 s, 60°C for 30 s, 72°C for 40 s for 24 cycles, and 72°C for 10 min. PCR primer sequences were as follows: for mouse Gapdh, 5′-ACCCAGAAGACTGTGGATGG-3′ and 5′-CACATTGGGGGTAGGAACAC-3′; for mouse Dmp1, 5′-CAGTGAGGATGAGGCAGACA-3′ and 5′-TCGATCGCTCCTGGTACT CT-3′; for mouse Dspp, 5′-GGAACTGCAGCACAGAATGA-3′ and 5′-CAGTGTTCCCCT GTTCGTTT-3; and for mouse BMP9, 5′-TGAGTCCCATCTCCATCCTC-3′ and 5′-ACCCACCAGACACAAGAAGG-3′. The 2−ΔΔCt value was used to calculate the relative gene expression normalized by the expression level of Gapdh.
Statistical analysis
Data were expressed as mean ± standard deviation. Statistical significances were determined by the Student's t-test or one-way analysis of variance with the use of SPSS 17.0 (SPSS, Inc., Chicago, IL). The differences between groups were statistically significant at *P < 0.05.
Results
Expression pattern of BMP9 during postnatal tooth development
Tooth development included two parts: crown development and root development. Generally, the crown continues to develop until PN4; the root starts to develop after crown formation and reaches its final length; and the molar erupts to the oral cavity about PN18 in the mice [35]. In this study, the result of H & E staining demonstrated that at the time of PN4 (Fig. 1A, A′), the crown of the first mandibular molar developed to its final morphology. At PN7, the Hertwig's Epithelial Root Sheath formed (Fig. 1B, B′). The root fraction appeared at PN11 (Fig. 1C, C′), and the root length continued to elongate through PN15 (Fig. 1D, D′). According to the findings, we selected PN4 as the time point for crown development; PN7, PN11, and PN15 as the time points of the initiation, early, and late stages of root development in our subsequent study. To determine whether BMP9 is expressed during postnatal crown and root development, we detected the BMP9 signal in the first mandibular molar by immunohistochemistry at PN4, 7, 11, and 15. On PN4 (Fig. 1E, E′), BMP9 expression was widely observed in odontoblasts, ameloblasts, dental pulp cells, and osteoblasts in alveolar bones. The expression patterns of BMP9 on days PN7 (Fig. 1F, F′), PN11 (Fig. 1G, G′), and PN 15 (Fig. 1H, H′) were similar to PN4. The findings indicate that BMP9 may play a role in postnatal tooth development.

Expression pattern of BMP9 in tooth germ during postnatal tooth development.
Macrographic morphology of the tooth in BMP9-KO mice
To investigate the function of BMP9 in tooth-alveolar bone complex, we established a BMP9-KO mice model. The BMP9 knockout mice were established and appropriately genotyped as shown in Figure 2A. The BMP9-KO mice were viable and fertile, and they did not display gross anatomical abnormalities. Although the detailed analyses of possible phenotypes in different tissues/organs are underway, this study focused on the effect of BMP9 deficiency on tooth development. To simplify the experimental process, we used a cohort of 3-month-old male BMP9-KO mice and their wild-type littermates for this study.
Macrographically, the BMP9-KO mice displayed an abnormal tooth phenotype. Specifically, the incisor tips of the BMP9-KO mice were abraded, compared with those of the wild-type mice (Fig. 2B). The extracted molars of BMP9-OK mice were smaller with flatter cusps and shorter roots, whereas the tooth cusps of the wild-type mice were sharp with longer roots (Fig. 2C). These results suggest that BMP9 deficiency may negatively impact the mouse incisor and molar tooth development.
Micro-CT analysis of tooth-alveolar bone complex structure in BMP9-KO mice
Quantitative high-resolution analysis of the micro-CT image data further demonstrated that BMP9-KO mice had a shorter root, bigger apical foramen, and a lower alveolar ridge, compared with those of the wild-type animals (Fig. 3A). Moreover, the root canal of the first molar from BMP9-KO mice was significantly enlarged whereas the dentin wall was thinner (Fig. 3A). Figure 3B demonstrated the method to measure the structural parameters of tooth and alveolar bone listed in C–I. Statistical analysis revealed that the root length and dentin thickness of the BMP9-KO group were significantly reduced (Fig. 3C, D). The BMP9-KO mice exhibited a marked decrease in alveolar ridge height (Fig. 3E),

Micro-CT analysis of the tooth-alveolar bone complex of BMP9-KO mice.
Tooth abnormalities in BMP9-KO mice determined by 3-D reconstruction mimics analysis
We further carried out the 3-D reconstruction analysis to model tooth abnormalities in the absence of BMP9. Representative 3-D reconstruction images revealed that the first molar of BMP9-KO mice had a shorter root, bigger apical foramen, and thinner dentin compared with the wild-type in both maxilla and mandible (Fig. 4A, B). Moreover, the incisor tips of BMP9-KO mice were defective and dental pulp chambers were exposed, which were intact without any exposed pulp chambers in the wild-type incisors (Fig. 4C). When the root length and apical foramen width were determined, the root length was significantly decreased (Fig. 4D), whereas apical foramen width was increased in the BMP9-KO group (Fig. 4E). Quantitative analysis further revealed that dentin thickness was significantly decreased in the BMP9-KO group (Fig. 4F). Thus, this 3-D reconstruction mimics analysis further confirms that the deletion of BMP9 may significantly inhibit the normal development of the tooth.

3-D reconstruction analysis of the tooth of BMP9-KO mice.
H & E and immunohistochemical staining of teeth in BMP9-KO mice
Histological stains confirmed the lack of BMP9, resulting in significant tooth abnormalities in the tooth tissues retrieved from BMP9-KO mice (Fig. 5A, B). Specifically, H & E staining revealed that the odontoblasts were abundantly presented in polarized and well-organized single layers of cells in the wild-type mice, which was disorganized and formed multiple layers in the BMP9-KO mice (Fig. 5A). Further, BMP9-KO mice exhibited an enlarged pulp canal and apical foramen with thinner root dentin, compared with those of the wild-type control group (Fig. 5B).

H & E and immunohistochemical staining of tooth in BMP9-KO mice.
For immunohistochemical staining, there were almost no positively stained cells in the BMP9-KO mice tooth, whereas the BMP9 expression was detected in odontoblasts and dental pulp cells in wild-type mice (Fig. 5C), confirming that BMP9 was effectively deleted in the BMP9-KO mice.
Silencing BMP9 expression decreases osteo-/odontoblastic marker expression in dental progenitor cells
To further explore how BMP9 regulates osteo-/odontogenic differentiation of dental stem cells, we transduced the iSCAP cells with adenovirus overexpressing BMP9 or expressing siRNAs that silence mouse BMP9 expression. The iSCAPs infected with adenovirus expressing only GFP (AdGFP) were used as controls. The transduction efficiency was indicated by the GFP or RFP expression proportion of the cells, and it was improved with the increasing MOIs of AdBMP9 or AdsiBMP9 at 48 h after infection (Fig. 6A). When iSCAP cells were infected with increasing MOIs of AdBMP9, there was a trend of increasing ALP activity at day 5, whereas ALP activity was decreased when iSCAP cells were infected by increasing MOIs of AdsiBMP9 compared with controls (Fig. 6B, C). Further, the odontogenic markers in iSCAPs, Dmp1 and Dspp, were decreased by silencing the BMP9 expression, whereas they increased when the BMP9 was overexpressed compared with the AdGFP-infected iSCAPs control group (Fig. 6D). Thus, these results strongly suggest that BMP9 may play an important role in regulating the osteo-/odotoblastic differentiation of dental stem cells, such as iSCAPs, and thus may contribute to the normal developmental process of the teeth.

Silencing BMP9 expression decreases osteo-/odontoblastic marker expression in dental progenitor cells.
Discussion
In this study, we established the BMP9-knockout mouse model and analyzed the role of BMP9 in tooth-alveolar bone complex development. We found that BMP9-KO mice showed apparent defects in the tooth-alveolar bone complex, similar to the phenotypes manifested by dentinogenesis imperfecta. Further, we demonstrated that silencing BMP9 expression in iSCAP cells led to decreased expression of odontogenic differentiation makers, Dspp and Dmp1. Taken together, our results strongly suggest that BMP9 may play an important role in regulating tooth development. The novel finding may trigger future studies that are devoted to exploring how BMP9 functions in tooth development and the therapeutic uses of BMP9 for the bioengineering of replacement teeth.
BMP9 is a multiple-functional growth and differentiation factor and it plays a critical role in bone development [36]. Both dentin and bone are mineralized tissues, and they share many similarities in their biochemical properties and biomechanical compositions [37]. However, the role of BMP9 in dentinogenesis and tooth-alveolar bone complex formation is unclear. In an attempt to clarify the role of BMP9 in tooth development, we detected the BMP9 expression in tooth germs. According to the results of immunohistochemical staining, the expression of BMP9 was observed in odontoblasts, ameloblasts besides its expression in dental pulp and osteoblasts in alveolar bone during postnatal tooth development. The wide and intensive expression of BMP9 in the tooth germ suggests that BMP9 plays an important role in tooth development. Although some other BMP molecules, including BMP2, BMP4, and BMP7, were also detected in odontoblasts and ameloblasts during the dentinogenesis and amelogenesis [24,38,39], the defects in the tooth of BMP9-KO mice suggest that the absence of BMP9 cannot be compensated by other BMP molecules.
Dentinogenesis imperfect III (DI-III) is a genetic disease in humans that is characterized by severe dentin hypomineralization, thinner and shorter roots, and pulp enlargement occurring during the tooth development [40 –42]. In our study, micro-CT and 3-D reconstruction analysis of the BMP9 mutant mouse tooth displayed reduced thickness dentin, enlarged pulp canals, and shortened roots. These characteristics of BMP9-KO mice are similar to those of DI-III. To date, several studies have reported that molecular regulation is necessary for dentinogenesis and the root development.
Dspp is the terminal differentiation marker of odontoblasts and is abundant in the dentin matrix. The predentin in the Dspp gene deletion mouse is hypomineralized, similar to human dentinogenesis imperfecta Type III [43]. Dspp null mice exhibit impaired tooth and alveolar bone development that persist through postnatal growth, including remarkable alveolar bone loss, lower BV/TV and mineral density, and irregular tooth root [44 –46]. These changes in dentin and alveolar bone found in the Dspp null mice are similar to those observed in our BMP9-KO mutations. Dmp1 is a key regulator of odontoblast differentiation, and the expression of Dmp1 is required in both early and late odontoblasts for normal odontogenesis and mineralization [13,47]. Dmp1 gene loss mice exhibit expansion of the pulp cavities and root canals and thin dentin [15,48], which had some similarities to the manifestations of BMP9-KO mice. The re-expression of Dmp1 in odontoblasts rescued the defects of dentin mineralization in Dmp1 null mice [47]. As shown in our studies, both Dspp and Dmp1 were significantly induced by BMP9, whereas their expression was reduced when BMP9 was silenced, suggesting that both Dspp and Dmp1 may be critical downstream targets of BMP9 signaling in dental development. Nonetheless, it remains to be determined clinically whether the lack of or decreased BMP9 expression is associated with the development of dentinogenesis imperfecta.
Teeth are stabilized on the alveolar bone by periodontal ligament, and the well-developed alveolar bone is important for tooth function. It was reported that appropriate subcrestal BMD and height of the alveolar bone and the alveolar ridge are important for supporting the tooth [49]. In our study, we found BMP9 expression in alveolar bone during the stages of tooth germ, suggesting that BMP9 may play a part in alveolar bone development. Further, we found that the adult BMP9-KO mice had a shorter alveolar bone and decreased mineral density,
Conclusions
In this study, BMP9-KO mice displayed defects in the tooth-alveolar bone complex. The BMP9 null mice demonstrated thinner dentin, shorter roots, and enlarged root pulp canals that resemble the manifestations of DI-III. Moreover, the alveolar bone in BMP9-KO mice was shorter and hypomineralization was observed. Mechanistically, we found that the expression of Dspp and Dmp1 was inhibited when BMP9 was silenced in iSCAPS, suggesting that Dspp and Dmp1 may be critical downstream targets of BMP9 signaling in dental development. Nonetheless, further studies are required to determine whether the lack of or decreased BMP9 expression is associated with the development of dentinogenesis imperfecta clinically.
Footnotes
Acknowledgments
The reported work was supported in part by research grants from the National Natural Science Foundation of China (#81870758 to HZ), Chongqing Research Program of Basic Research and Frontier Technology (#cstc2017jcyjAX0020 to HZ), the Program for Innovation Team Building at Institutions of Higher Education in Chongqing in 2016 (#CXTDG201602006), the National Institutes of Health (CA226303 to TCH), and the National Key Research and Development Program of China (2016YFC1000803 and 2011CB707906). TCH was also supported by the Mabel Green Myers Research Endowment Fund and The University of Chicago Orthopaedic Surgery Alumni Fund. Funding sources were not involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the article; and in the decision to submit the article for publication.
Author Disclosure Statement
No competing financial interests exist.
